Plafki C, Carl U M, Glag M, Hartmann K A
Center for Hyperbaric Medicine, Luebeck.
Strahlenther Onkol. 1998 Nov;174 Suppl 3:66-8.
Late radiation injuries may impose a negative influence on the quality of life in the affected patients. In several entities, standardized treatment protocols are lacking. Hyperbaric oxygenation (HBO) has been shown to have beneficial effects in the treatment of late radiation sequelae.
The basic principles of HBO are reviewed as well as clinical issues. Current study protocols are presented.
During HBO-therapy the patient breathes pure oxygen at pressures above 100 kPa. The oxygen solubility within the fluid phase of the blood is largely increased. Biological effects include an increased oxygen diffusibility, improved collagen synthesis and neoangiogenesis as well as an enhancement of antimicrobial defenses. By decreasing the capillary filtration pressure a reduction of edema becomes possible. HBO has been shown to prevent complications following surgery in irradiated tissues. Its efficacy as an adjunct in the treatment of osteonecroses in radiation patients could be demonstrated. In addition, the loss of osseointegrated implants in the maxillofacial bones of these patients could be significantly reduced. Further indications include soft tissue necroses, hemorrhagic cystitis and proctitis in tumor patients that have been treated by radiotherapy as part of a multimodality approach.
HBO in the treatment of late radiation effects is still subject of investigation, but remarkable results have been reported. Optimized treatment protocols need to be determined in various entities. The rate of side effects is acceptable low.
晚期放射性损伤可能会对受影响患者的生活质量产生负面影响。在一些情况下,缺乏标准化的治疗方案。高压氧疗(HBO)已被证明在治疗晚期放射性后遗症方面具有有益效果。
回顾了高压氧疗的基本原理以及临床问题。介绍了当前的研究方案。
在高压氧治疗期间,患者在高于100 kPa的压力下呼吸纯氧。血液液相中的氧溶解度大幅增加。生物学效应包括增加氧扩散性、改善胶原蛋白合成和新血管生成以及增强抗菌防御能力。通过降低毛细血管滤过压,有可能减轻水肿。高压氧疗已被证明可预防受照射组织手术后的并发症。其作为辅助手段治疗放射性骨坏死患者的疗效得到了证实。此外,这些患者颌面部骨中骨整合种植体的丢失可显著减少。其他适应症包括作为多模式治疗一部分接受放疗的肿瘤患者的软组织坏死、出血性膀胱炎和直肠炎。
高压氧疗在治疗晚期放射性效应方面仍在研究中,但已报道了显著的结果。需要在各种情况下确定优化的治疗方案。副作用发生率低至可接受。